AHR Relative Valuation
AHR's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, AHR is overvalued; if below, it's undervalued.
Historical Valuation
American Healthcare REIT Inc (AHR) is now in the Fair zone, suggesting that its current forward PS ratio of 2.57 is considered Fairly compared with the five-year average of 602.49. The fair price of American Healthcare REIT Inc (AHR) is between 29.00 to 43.19 according to relative valuation methord.
Relative Value
Fair Zone
29.00-43.19
Current Price：36.65
Fair
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
2.55
P/B
Median3y
1.59
Median5y
1.59
2.62
FCF Yield
Median3y
3.81
Median5y
3.81
Competitors Valuation Multiple
The average P/S ratio for AHR's competitors is 5.42, providing a benchmark for relative valuation. American Healthcare REIT Inc Corp (AHR) exhibits a P/S ratio of 2.57, which is -52.52% above the industry average. Given its robust revenue growth of 8.22%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
FAQ
Is American Healthcare REIT Inc (AHR) currently overvalued or undervalued?
What is American Healthcare REIT Inc (AHR) fair value?
How does AHR's valuation metrics compare to the industry average?
What is the current P/B ratio for American Healthcare REIT Inc (AHR) as of Jul 13 2025?
What is the current FCF Yield for American Healthcare REIT Inc (AHR) as of Jul 13 2025?
What is the current Forward P/E ratio for American Healthcare REIT Inc (AHR) as of Jul 13 2025?